Cognitive Dysfunction: all 3,930 studies

Page 14 of 40. Open to participants first (1,114), then studies with results posted, then the rest; newest registration first within each.

• NAD Therapy for Improving Memory and Brain Blood Flow in Older Adults With Mild Cognitive ImpairmentCompletedNCT03482167Phase 1/2Results posted
• Movement Intervention for Memory EnhancementCompletedNCT03475316Not applicableResults posted
• Testing Ramipril to Prevent Memory Loss in People With GlioblastomaCompletedNCT03475186Phase 2Results posted
• Optimizing Function and Independence Through iHI-FIVESCompletedNCT03474380Not applicableResults posted
• Brain Energy for Amyloid Transformation in Alzheimer's Disease StudyCompletedNCT03472664Not applicableResults posted
• Safety and Immunogenicity of Repeated Doses of ABvac40 in Patients With a-MCI or Vm-ADCompletedNCT03461276Phase 2Results posted
• Treatment of Mild Cognitive Impairment With Transcutaneous Vagal Nerve StimulationCompletedNCT03359902Not applicableResults posted
• Ageing and Health. Spanish Longitudinal StudyActive, not recruitingNCT03343886Results posted
• Improvisational Movement for People With Memory Loss and Their CaregiversCompletedNCT03333837Not applicableResults posted
• Noninvasive Brain Stimulation for Mild Cognitive ImpairmentCompletedNCT03331796Not applicableResults posted
• Effect of IVIG on Cerebral and Retinal Amyloid in Mild Cognitive Impairment Due to Alzheimer DiseaseCompletedNCT03319810Phase 2Results posted
• Dietary Ketosis: Fatty Acids Activate AMPK Energy Circuits Modulating Global MethylationCompletedNCT03319173Not applicableResults posted
• Memory and Antioxidants in Vascular Impairment TrialCompletedNCT03306979Phase 2Results posted
• Applying a Person-Centered Approach to Enhance Cognitive Training in Senior Living Community Residents With Mild Cognitive ImpairmentCompletedNCT03292705Not applicableResults posted
• Remediation of Age-related Cognitive Decline: Vortioxetine and Cognitive TrainingCompletedNCT03272711Phase 4Results posted
• Napping, Sleep, Cognitive Decline and Risk of Alzheimer's DiseaseTerminatedNCT03256539Not applicableResults posted
• Aging and Cognitive Health Evaluation in Elders (ACHIEVE)CompletedNCT03243422Not applicableResults posted
• Multicultural Healthy Diet to Reduce Cognitive DeclineCompletedNCT03240406Not applicableResults posted
• Parkinson Disease and DBS: Cognitive Effects in GBA Mutation CarriersCompletedNCT03234478Results posted
• Cognitive Rehabilitation Therapy for Mild Cognitive ImpairmentCompletedNCT03225482Not applicableResults posted
• Curcumin and Vascular and Cognitive Function in Patients With Chronic Kidney DiseaseCompletedNCT03223883Phase 2Results posted
• Cognitive Training and Neuroplasticity in Mild Cognitive ImpairmentCompletedNCT03205709Not applicableResults posted
• IMProving Executive Function StudyCompletedNCT03187353Phase 4Results posted
• Low-Dose Ibuprofen in Improving Cognitive Impairment in Patients With CancerCompletedNCT03186638Phase 2Results posted
• Lithium As a Treatment to Prevent Impairment of Cognition in EldersCompletedNCT03185208Phase 4Results posted
• Reducing Breast Cancer-related Fatigue and Improving Cognition With Non-Invasive Brain StimulationTerminatedNCT03143894Not applicableResults posted
• Cerebral Haemodynamic Changes During Cognitive Testing: A fTCD StudyCompletedNCT03134963Results posted
• Application of Transcranial Alternating Current Stimulation for Modulation of Sleep and Cognitive PerformanceTerminatedNCT03112902Not applicableResults posted
• Nicotinamide as an Early Alzheimer's Disease TreatmentCompletedNCT03061474Phase 2Results posted
• Flortaucipir 18F PET Imaging in BIOCARD StudyTerminatedNCT03052972Phase 1Results posted
• Trial of Sirolimus for Cognitive Impairment in Sturge-Weber SyndromeCompletedNCT03047980Phase 2/3Results posted
• Problem Adaptation Therapy for Mild Cognitive Impairment and DepressionCompletedNCT03043573Not applicableResults posted
• COcoa Supplement and Multivitamin Outcomes Study for the MindCompletedNCT03035201Results posted
• A Study of LY3303560 in Participants With Mild Cognitive Impairment or Alzheimer's DiseaseCompletedNCT03019536Phase 1Results posted
• Involving Family to Improve Communication in Primary CareCompletedNCT02986958Not applicableResults posted
• Genomic Outcomes of MetforminCompletedNCT02986659Phase 4Results posted
• Video-Enhanced Care Management for Medically Complex VeteransCompletedNCT02962687Not applicableResults posted
• Intranasal Inhalations of Bioactive Factors Produced by M2 Macrophages in Patients With Organic Brain SyndromeCompletedNCT02957123Phase 1/2Results posted
• The Effectiveness of TECH: Tablet Enhancement of Cognition and HealthCompletedNCT02955277Not applicableResults posted
• A Study to Evaluate the Effects of Basmisanil in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS) Treated With AntipsychoticsCompletedNCT02953639Phase 2Results posted
• Effects of IV-Administered Ca-DTPA and Zn-DTPA To Treat Patients With Gadolinium Deposition DiseaseTerminatedNCT02947022Phase 1/2Results posted
• Cognitive Remediation for Alcohol Use Disorder and Posttraumatic Stress DisorderCompletedNCT02929979Not applicableResults posted
• Preoperative Cognitive Screening in Older Spinal Surgical PatientsCompletedNCT02922634Results posted
• Cognitive Training in Parkinson StudyCompletedNCT02920632Not applicableResults posted
• TAK-071 Scopolamine-Induced Cognitive Impairment StudyTerminatedNCT02918266Phase 1Results posted
• An Open-Label Study Investigating MK-8931 in Participants With Mild and Moderate Hepatic Insufficiency (MK-8931-016)CompletedNCT02910739Phase 1Results posted
• Prevention of Early Postoperative DeclineCompletedNCT02908464Not applicableResults posted
• Intervention to Reduce Sedentary TimeCompletedNCT02878486Not applicableResults posted
• Internet-based Conversational Engagement Clinical TrialCompletedNCT02871921Not applicableResults posted
• Impact of Combined Behavioral Interventions on Cognitive Outcomes in MCICompletedNCT02864069Not applicableResults posted
• A Study To Evaluate The Safety And Efficacy Of PF-04958242 In Subjects With Cognitive Impairment Associated With Schizophrenia (CIAS)TerminatedNCT02855411Phase 2Results posted
• Cognitive Enhancement Through Transcranial Laser TherapyCompletedNCT02851173Phase 2Results posted
• The Influence of Postoperative Analgesia on Systemic Inflammatory Response and POCD After Femoral Fractures SurgeryCompletedNCT02848599Phase 2Results posted
• Evaluation of a Computerized Complex Instrumental Activities of Daily Living Marker (NMI)CompletedNCT02843529Not applicableResults posted
• Phase 3 Randomized Placebo Controlled Clinical Trial of DonepezilCompletedNCT02822573Phase 3Results posted
• Exercise in Adults With Mild Memory ProblemsCompletedNCT02814526Not applicableResults posted
• Comparison of PET Amyloid Imaging in Japanese and Western SubjectsCompletedNCT02813070Phase 2Results posted
• 11C-Acetate PET/CT Imaging As a Biomarker of Amyloid-Induced NeuroinflammationTerminatedNCT02811744Phase 2Results posted
• SYNchronizing Exercises, Remedies in GaIt and CognitionTerminatedNCT02808676Not applicableResults posted
• BI 425809 in Patients With Cognitive Impairment Due to Alzheimer's Disease.CompletedNCT02788513Phase 2Results posted
• Study of TAK-071 in Healthy Participants and Participants With Mild Cognitive Impairment/Mild Alzheimer Disease and Relative Bioavailability (BA) and Food Effect of TAK-071 in Healthy ParticipantsTerminatedNCT02769065Phase 1Results posted
• Electrophysiological Biomarkers of Chemotherapy-related Cognitive Impairment and RecoveryCompletedNCT02767388Results posted
• Cognitive Recovery After Electroconvulsive Therapy and General AnesthesiaCompletedNCT02761330Not applicableResults posted
• Memory Improvement Through Nicotine Dosing (MIND) StudyCompletedNCT02720445Phase 2Results posted
• The "Light for the Brain" StudyCompletedNCT02677987Not applicableResults posted
• Mindfulness-Based Stress Reduction, Health Education and ExerciseCompletedNCT02665481Not applicableResults posted
• Cognitive Training in the Treatment of AUDCompletedNCT02664038Not applicableResults posted
• A Policy Relevant US Trauma Care System Pragmatic Trial for PTSD and ComorbidityCompletedNCT02655354Not applicableResults posted
• Candesartan's Effects on Alzheimer's Disease And Related BiomarkersCompletedNCT02646982Phase 2Results posted
• Cog-VACCINE: Cognitive Training in Patients With Vascular Cognitive Impairment, no DementiaCompletedNCT02640716Not applicableResults posted
• Repetitive Transcranial Magnetic Stimulation for DementiaCompletedNCT02621424Not applicableResults posted
• A Study of LY2599666 in Healthy Participants and Participants With Mild Cognitive Impairment or Alzheimer's Disease (AD)TerminatedNCT02614131Phase 1Results posted
• Water-based Activity to Enhance Recall in VeteransCompletedNCT02614092Not applicableResults posted
• Brain and Cognitive Changes After Reasoning Training in Individuals With Mild Cognitive ImpairmentCompletedNCT02596906Not applicableResults posted
• Phenytoin for Memory Impairment Secondary to MegestrolCompletedNCT02595723Phase 4Results posted
• Cognitive Ability Training in SeniorsCompletedNCT02587338Not applicableResults posted
• Phase II Trial of Tesamorelin for Cognition in Aging HIV-Infected PersonsCompletedNCT02572323Phase 2Results posted
• [18F]MK-6240 Positron Emission Tomography (PET) Tracer First-in-Human Validation Study (MK-6240-001)CompletedNCT02562989Phase 1Results posted
• The Impact of Ketamine on Postoperative Cognitive Dysfunction, Delirium, and Renal DysfunctionCompletedNCT02554253Phase 2Results posted
• CPAP to Treat Cognitive Dysfunction in MSCompletedNCT02544373Not applicableResults posted
• Validity of the Electronic Self-Administered Gerocognitive Examination (eSAGE)CompletedNCT02544074Results posted
• Mirabegron in Parkinson Disease and Impaired CognitionCompletedNCT02536976Phase 4Results posted
• Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's DiseaseTerminatedNCT02503501Phase 2Results posted
• Effect of Heat Exposure on Cognition in Persons With TetraplegiaCompletedNCT02488824Not applicableResults posted
• Cognitive Dysfunction In Parkinson'sCompletedNCT02468804Not applicableResults posted
• An Investigation Into the Effects of a Wild Blueberry Powder and a Wild Blueberry Extract on Cognition in Older AdultsCompletedNCT02446314Not applicableResults posted
• Clinical Pharmacology of p38 MAP Kinase Inhibitor, VX-745, in Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild ADCompletedNCT02423200Phase 2Results posted
• A PET Study of the Effects of p38 MAP Kinase Inhibitor, VX-745, on Amyloid Plaque Load in Alzheimer's Disease (AD)CompletedNCT02423122Phase 2Results posted
• Effect of Elderberry Juice on Cognition and Inflammation in Patients With Mild Cognitive ImpairmentCompletedNCT02414607Phase 1/2Results posted
• Early-onset Obesity and Cognitive Impairment in Children With PseudohypoparathyroidismCompletedNCT02411461Results posted
• Effects of Methylene Blue in Healthy Aging, Mild Cognitive Impairment and Alzheimer's DiseaseCompletedNCT02380573Phase 2Results posted
• Thermoregulation and Cognition During Cool Ambient Exposure in TetraplegiaCompletedNCT02379156Phase 4Results posted
• Memantine Hydrochloride and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Reducing Neurocognitive Decline in Patients With Brain MetastasesCompletedNCT02360215Phase 3Results posted
• Cognitive Dysfunction in Parkinson's DiseaseCompletedNCT02346708Not applicableResults posted
• BI 409306 in Patients With Cognitive Impairment Due to Alzheimer's Disease.CompletedNCT02337907Phase 2Results posted
• A Policy Relevant US Trauma Care System Pragmatic Trial for PTSD and Comorbidity PilotCompletedNCT02335125Not applicableResults posted
• Physical Activity and Neuropsychological Outcomes in a Cancer PopulationCompletedNCT02332876Not applicableResults posted
• Ramelteon in the Prevention of Post-operative DeliriumCompletedNCT02324153Phase 2Results posted
• Dose-Finding Study To Evaluate Safety, Tolerability, and Efficacy of E2609 in Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (Prodromal Alzheimer's Disease) and Mild to Moderate Dementia Due to Alzheimer's DiseaseTerminatedNCT02322021Phase 2Results posted
• Amyloid Plaque Deposition in Chemotherapy-Induced Cognitive ImpairmentTerminatedNCT02317783Phase 2Results posted

← Cognitive Dysfunction overview